Numab Therapeutics lands $110m Series C
Numab Therapeutics AG, a clinical stage biopharmaceutical company, has raised about $110 million in Series C financing.
Numab Therapeutics AG, a clinical stage biopharmaceutical company, has raised about $110 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination